{"url_path":"/sec/mltx/8-k/2026-06-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1821586/0001213900-26-070362-index.html","accession_number":"0001213900-26-070362","cik":"0001821586","ticker":"MLTX","issuer_name":"MoonLake Immunotherapeutics","edgar_url":"https://www.sec.gov/Archives/edgar/data/1821586/0001213900-26-070362-index.html","primary_entity_key":"0001821586","primary_entity_name":"MoonLake Immunotherapeutics"},"word_count":97,"has_tables":true,"body_markdown":"** **\n\n**Item 9.01. Financial Statements and Exhibits.**\n\n** **\n\n(d) *Exhibits*. The following exhibits are\nbeing furnished herewith:\n\n \n\n**Exhibit\n\nNumber**\n \n**Exhibit Title or Description**\n\n99.1\n \n[Press Release, dated June 21, 2026](ea029539901ex99-1.htm)\n\n99.2\n \n[Slide Presentation, dated June 22, 2026](ea029539901ex99-2.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n 2\n\n \n\n \n\n**SIGNATURE**\n\n** **\n\nPursuant to the requirements of the Securities Exchange Act of 1934,\nthe registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n**MOONLAKE IMMUNOTHERAPEUTICS**\n\n \n \n\nDate: **June 22, 2026**\nBy:\n/s/ Matthias Bodenstedt\n\n \nName:\nMatthias Bodenstedt\n\n \nTitle:\nChief Financial Officer\n\n \n\n 3"}